Prolynx LLC engages in the development of proprietary drug delivery system for half-life extension of proteins, peptides, and small molecules. Its pipeline includes PLX038, PEG-PARP, IL-15, IL-2, PTH 1-34, GLP-1RA, and QMo IVT. The company was founded by Daniel V. Santi and Gary W. Ashley in 2010 and is headquartered in San Francisco, CA.

Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the bladder, where it is passed naturally from the body through normal urination. Sequana Medical’s first product, the Alfapump System, is an innovative solution for the management of ascites. Ascites is a fluid that collects in the abdominal cavity in people with advanced liver disease, certain cancers, or congestive heart failure. Alfapump System was the first and only system for the automatic and continual removal of ascites. Sequana Medical was founded in 2006 and is based in Zurich, Switzerland.

GlobeImmune, operates as a biopharmaceutical company. It engages in developing and manufacturing Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Its products include GI-3000, a Tarmogen for epidermal growth factor receptor over expressing tumors; GI-4000, a Tarmogen for mutated-Ras mediated cancers; GI-5005, a Tarmogen for chronic hepatitis C infection; GI-8000, a Tarmogen for influenza; and GI-10000 Targeted Ablation of Mutational Escape, a novel use of the Tarmogen platform that eliminates or prevents the emergence of mutated escape variants in patients receiving antiviral or targeted cancer therapies. GlobeImmune was founded in 1995 as Ceres Pharmaceuticals, Inc. The company is based in Louisville, Colorado.

Syntarga is a privately held biopharmaceutical company engaged in the discovery and development of proprietary Antibody-Drug Conjugate technology and products for the treatment of cancer. The Company's cutting-edge chemistry capabilities and unique know-how have led to the creation of its antibody empowering Potent Payload Technology. Syntarga is leveraging its proprietary technologies and expertise to generate and commercialize, alone and with partners, a portfolio of next generation Antibody-Drug Conjugate products.

Medical Components, Inc. manufactures and supports cutting-edge vascular access devices. Its products include needles, repair kits, dilators, guidewires, sheath dilators, and trocars and tunnelers for acute, long term, and short term hemodialysis, as well as central vein infusion and peritoneal dialysis applications. The company was founded in 1978 and is headquartered in Harleysville, PA.

The Paul Scherrer Institute (PSI) is a multi-disciplinary research institute which belongs to the Swiss Federal Institutes of Technology Domain covering also ETH Zurich and EPFL. It was established in 1988 through the merger of EIR (Eidgenössisches Institut für Reaktorforschung, Federal Institute for Reactor Research, established in 1960) and SIN (Schweizerisches Institut für Nuklearphysik, Swiss Institute for Nuclear Physics, established in 1968). It is based in Villigen and Würenlingen.

Part of Amgen, Inc., Amgen Research (Munich) GmbH is a German company located in Munich. The firm produces copper and metal powders. Robert Saller and Peter Kufer are the current co-CEOs of the firm. On June 13, 2002 ECKA Granulate GmbH & Co. KG acquired Amgen Research (Munich) GmbH from Aurubis AG.

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

By-health Co., Ltd. engages in the research, development, production, and sales of vitamin and dietary supplements. Its dietary supplements include vitamins, minerals and animal and plant extracts. The company's nutritional products include protein, eye nutrition, vigor enhancement, childhood nutrition, nutrition of pregnant, reproductive vitamin and minerals for heart and cerebral vessel, bone and joint, beauty maintenance, and immunity boosting. By-health was founded in October 1995 and is headquartered in Guangzhou, China.

Shire LLC provides pharmaceutical services. The company was founded in 2004 and is headquartered in Florence , KY.

AltruBio is focused on developing targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. AltruBio International in Delaware with principal office in SFO Bay Area California is a biopharmaceutical company integrated globally and virtually to develop targeted antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. With its R&D foundation in Taipei Taiwan since June 2000, AbGenomics has been focusing on the discovery and development of novel therapeutics for unmet medical needs. Their R&D scientists built an efficient discovery platform to identify and validate novel antibody therapeutics. Currently, AbGenomics has several potential therapeutic antibodies targeting autoimmune diseases, pancreatic cancer, stomach cancer, colorectal cancer, ovarian cancer, lung cancer, and other solid tumors in various development stages.

Bioalliance Cv is a Dutch private company that functions as an investment holding and financing company.

Sarstedt AG & Co. KG engages in the provision of laboratory and medical equipment. It develops, manufactures and sells equipment and consumables in the medicine and research fields. Its products include offers electric tube strippers, blood gas capillaries, and capillary blood collection. The company was founded by Walter Sarstedt on May 1, 1961 and is headquartered in Nuembrecht, Germany.

Nanjing Xinhuan Testing Technology Co., Ltd., established on 2018-09-26, Business scope includes food,Healthy food,medicine,skin care products,cosmetic,Testing of baby products;Commodity Information Consulting Service;biotechnology development,technical consulting,Technical Services,technology transfer;design,make,release,Acting for various domestic and foreign advertisements;Marketing Planning Service;medicine,food technology development,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of experimental analysis instruments;Experimental analysis instrument sales;Instrument sales;software development;software sales;Wholesale of aquatic products;Aquatic product retail(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Watkins-Conti Products provides effective solutions that address both the causes & symptoms of incontinence in women. Women's healthcare company devoted to innovation + development of affordable, effective solutions for common life altering difficulties encountered in today's environment.